Showing results (21-30 of 1,656) with videos related to

Sort By:
Pageof 166
Atherosclerosis. Supplements|May 5, 2015
Effects of different lipoprotein apheresis methods on serum protein levelsU Julius, G Siegert, H Kostka, et al.
Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Metabolisme|December 14, 2007
The health status of Russian-speaking immigrants in GermanyS Tselmin, W Korenblum, M Reimann, et al.
Atherosclerosis. Supplements|January 30, 2013
Differential effects of lipoprotein apheresis by lipidfiltration or dextran sulfate adsorption on lipidomic profileJ Gräßler, S Kopprasch, J Passauer, et al.
Atherosclerosis. Supplements|May 5, 2015
TIDILAP: Treatment of iron deficiency in lipoprotein apheresis patients --A prospective observational multi-center cohort study comparing efficacy, safety and tolerability of ferric gluconate with ferric carboxymaltoseU Schatz, B M W Illigens, T Siepmann, et al.
Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Metabolisme|April 12, 2022
Precision Medicine Approach for Cardiometabolic Risk Factors in Therapeutic ApheresisX Yin, K Takov, R Straube, et al.
Diabetologia|March 24, 2007
Glycoxidised LDL isolated from subjects with impaired glucose tolerance increases CD36 and peroxisome proliferator-activator receptor gamma gene expression in macrophagesJ Graessler, J Pietzsch, T Westendorf, et al.
Atherosclerosis. Supplements|May 5, 2015
Detailed description of the cardiovascular situation in patients who have started lipoprotein apheresis treatmentS Schampera, S Fischer, N Weiss, et al.
Atherosclerosis. Supplements|January 30, 2013
Single whole blood dextran sulfate adsorption favorably affects systemic oxidative balance in lipoprotein apheresis patientsS Kopprasch, S R Bornstein, P E H Schwarz, et al.
Atherosclerosis. Supplements|February 5, 2010
A single lipid apheresis does not modulate pulse wave reflection in hypercholesterolemic patientsJ Passauer, K Herbrig, S Fischer, et al.
Der Internist|March 6, 2012
[Benefits and risks of current pharmacotherapy in the treatment of type 2 diabetes]C Schindler, A Barthel, S Fischer, et al.
Pageof 166